Characteristics | All patients n = 15 (%) |
---|---|
Age (years) | |
≤ 40 | 4 (26.7) |
41–50 | 3 (20) |
51–60 | 3 (20) |
≥ 60 | 5 (33.3) |
Surgery | |
Breast conserving surgery | 13 (86.7) |
Mastectomy | 2 (13.3) |
Radiotherapy | |
Yes | 10 (66.7) |
No | 5 (33.3) |
Chemotherapy | |
Yes | 3 (20) |
No | 12 (80) |
Endocrine therapy | |
Yes | 5 (33.3) |
No | 10 (66.7) |
SLNB | |
Yes | 6 (40) |
No | 9 (60) |
Estrogen receptor status | |
Positive | 5 (45.5) |
Negative | 6 (54.5) |
Not recorded | 4 |
HER2 status | |
Positive | 1 (10) |
Negative | 9 (90) |
Not recorded | 5 |
Tumor size (mm) | |
0–10 | 5 (33.3) |
11–20 | 7 (46.7) |
> 20 | 3 (20) |
Mitosis count/10 HPF | |
0–2 | 0 |
2–4 | 8 (53.3) |
> 4 | 1 (6.7) |
Not recorded | 6 (40) |